Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of British Columbia

$210,000.00

Development of polymer-lipid hybrid nanoparticles for enhanced gene delivery

FY 2024-25

Summary
My project is focused on developing a new type of tiny particles called polymer-lipid hybrid nanoparticles (pLNP) to improve how genes are delivered to cells both in the liver and throughout the body. These particles are designed to overcome two big problems with current technology: poor release of genetic material inside cells and limited ability to target cells outside the liver. By using special pH-sensitive materials, pLNPs aim to release their genetic cargo more effectively inside cells and reach a broader range of tissues beyond the liver. This innovation could significantly advance gene therapy, which involves delivering therapeutic genes to treat various diseases. I will use advanced techniques to create and test a wide variety of pLNPs in living organisms. I will build a library of different formulations, each with unique targeting and delivery capabilities. In the future, the best formulations can be selected from my library to deliver genes specifically and efficiently to treat different diseases.
Program
CIHR Fellowship
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
513199
Name
Wu Jiamin
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Development of polymer-lipid hybrid nanoparticles for enhanced gene delivery
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$210,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Drug Delivery; Gene Therapy; Lipid Nanoparticles; Polymer
Abstract
My project is focused on developing a new type of tiny particles called polymer-lipid hybrid nanoparticles (pLNP) to improve how genes are delivered to cells both in the liver and throughout the body. These particles are designed to overcome two big problems with current technology: poor release of genetic material inside cells and limited ability to target cells outside the liver. By using special pH-sensitive materials, pLNPs aim to release their genetic cargo more effectively inside cells and reach a broader range of tissues beyond the liver. This innovation could significantly advance gene therapy, which involves delivering therapeutic genes to treat various diseases. I will use advanced techniques to create and test a wide variety of pLNPs in living organisms. I will build a library of different formulations, each with unique targeting and delivery capabilities. In the future, the best formulations can be selected from my library to deliver genes specifically and efficiently to treat different diseases.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wu, Jiamin
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $210,000~ $0~